top of page

Palliative Care and Pulmonary Arterial Hypertension

Updated: Nov 7, 2024

In other diseases, palliative care is associated with better quality of life, symptom management, illness understanding, and reduced caregiver burden. This study looked at when palliative care specialty teams should be brought in as an adjunct to ongoing disease-directed care for pulmonary arterial hypertension (PAH).


They suggest that PAH clinicians educate patients about palliative care's role and refer all patients in a "high risk" category to the palliative care team. This provides an opportunity to facilitate living as well as possible through symptom management and coping support regardless of a patient's disease prognosis or clinical status.




 
 
 

Recent Posts

Promising results for drug candidate CS1

This press release reports that over the 12 months of their Expanded Access Program enrolling ten patients, the majority of patients with pulmonary arterial hypertension who completed treatment with d

 
 
 
Using sotatercept off-label in children

Clinical trials for sotatercept didn't include children, so any pediatric use is off-label. This study, conducted at one children's hospital in San Diego, evaluated sotatercept in 7 pediatric patients

 
 
 

Comments


PHA Canada

408 - 55 Water Street

Office 8928

Vancouver, BC, V6B 1A1

Email: info@phacanada.ca

Phone: 604-682-1036

Toll Free: 1-877-774-2226

Charitable Registration # 872050224RR0001

  • Instagram
  • Facebook
  • X
  • LinkedIn
  • Youtube

Copyright 2025 PHA CANADA, ALL RIGHTS RESERVED   |   Website created by Creativibe

bottom of page